Clinical Trial Update: Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with capecitabine plus oxaliplatin or irinotecan in metastatic colorectal cancer was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Colorectal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2008-12-02